Mandate

Vinge advises STMicroelectronics on its acquisition of a majority stake in Norstel AB

February 07, 2019 M&A

Vinge has advised the French-Italian electronics and semiconductor manufacturer STMicroelectronics in connection with STMicroelectronics entering into an agreement to acquire a majority stake in the Swedish silicon carbide wafer manufacturer Norstel AB.

Upon completion of the transaction (which is subject to conditions), STMicroelectronics will acquire 55% of Norstel AB, with an option to acquire the remaining 45% subject to certain conditions. If such option is exercised, it will result in a total consideration of USD 137,500,000 for 100% of Norstel AB.

Vinge’s team consisted of, among others, Christina Kokko, Ulrich Ziche, Linda Sengul and Desirée Sjöblom (Corporate and M&A), Gu Qun, Gabriella Fossum, Jasmin Draszka-Ali and Hayaat Ibrahim (Regulatory and Compliance), Klara Secher (IP), Sophia Holm and Lova Unge (Employment), Nicklas Thorgerzon (IT), Axel Jansson and Anna Åhlberg (Banking and Financing), Anne Wijkman (Real Estate/Lease Agreements), Trine Osen Bergkvist (Competition), Fredrika Hjelmberg (Commercial Agreements), Hampus Olsson (Environment) and Jessica Öijer (VDR assistant).
 

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026